In many stroke trials, we just by default exclude pregnant and breastfeeding women, for example, or quite often we exclude patients who could be pregnant. If they can’t tell us whether they’re pregnant or not, then we just exclude them out of precaution. That we can’t definitely not do because that’s the main population who’s affected by CVST. So by excluding those, first of all, you’d have a hard time enrolling patients because you don’t find that many middle-aged men who have CVST...
In many stroke trials, we just by default exclude pregnant and breastfeeding women, for example, or quite often we exclude patients who could be pregnant. If they can’t tell us whether they’re pregnant or not, then we just exclude them out of precaution. That we can’t definitely not do because that’s the main population who’s affected by CVST. So by excluding those, first of all, you’d have a hard time enrolling patients because you don’t find that many middle-aged men who have CVST. And it just would not reflect the true population that’s affected by the disease. I think certainly not having a general default pregnancy exclusion criterion is really important. That requires some justification because, of course, we need ionized radiation and we need contrast as well to treat these lesions. But then, on the other hand, there’s no other treatment options. So really, even in pregnant patients, we would go ahead with that, even in clinical routine. So there’s no reason to exclude them from the trials. And I think the other thing that’s really important, you mentioned the age, is the lack of an upper age limit. So I don’t think TO-ACT applied an upper age limit, and we certainly should not do that in future trials as well, just to avoid excluding really, really old patients. I think we also shouldn’t apply, for example, an active cancer exclusion criterion, because many patients with active cancer are in a hypercoagulable state, and they also tend to have more CVST. So really, probably liberal inclusion criteria, and certainly don’t exclude pregnant patients. That’s the only thing I can say. I know that may require some fighting with the regulatory agencies, but that’s, I think, what we have to do.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.